Mevalonate kinase deficiency (MKD; also known as hyper-IgD syndrome) is a rare autoinflammatory disorder caused by recessive hypomorphic mutations in the MVK gene.1 Impaired activity of mevalonate kinase, a crucial component of the mevalonate-cholesterol biosynthesis pathway, leads to decreased production of isoprenoid lipids, defective posttranslational protein prenylation, and cytosolic accumulation of unprenylated Rab proteins and other small GTPases in cells from patients with MKD.2 It has been proposed that excessive production of IL-1β from monocytes of patients with MKD is caused by loss of protein prenylation, specifically geranylgeranylation.
No takes yet. Share an insight, caveat, or question.
Skinner et al. (2019) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: